Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
NCT00984542
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
bendamustine hydrochloride
Sponsor
Vanderbilt-Ingram Cancer Center
Collaborators
[object Object]